Ledger.Open graph →

SEC Form D · filed April 5, 2017

Antiva Biosciences, Inc

Offering

$22.3M

Sold

$11.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Vinzenz P. Ploerer · South San Francisco, CADirector Gail Maderis · South San Francisco, CAExec · Director Sarah P. Walter · South San Francisco, CAExec Michael D. Cannon · San Diego, CADirector Steven P. James · South San Francisco, CADirector Wendee S. Hutton · South San Francisco, CADirector David P. Kabakoff · South San Francisco, CADirector Oranee D. Daniels · South San Francisco, CAExec Ronald K. Rybar · Fenton, MIDirector William H. Dery · Fenton, MIExec Ronald L. Justice · Fenton, MIDirector Thomas P. Mckenney · Fenton, MIDirector Aaron D. Wirsing · Fenton, MIDirector Brian P. Petty · Fenton, MIDirector Randy D. Hicks · Fenton, MIExec · Director Steven T. Krause · Fenton, MIExec Keith Bley · South San Francisco, CAExec Jake J. Saper · Philadelphia, PADirector Mitchell J. Stewart · Philadelphia, PAExec · Director Amish J. Jani · Philadelphia, PAExec Ryan J. Shmeizer · Philadelphia, PADirector Allison B. Nolan · Grand Cayman, Cayman IslandsDirector Ronald Mass · Santa Monica, CADirector Andrew J. Sparacia · Cleveland, OHDirector David J. Swentor · Cleveland, OHExec Keith Bley · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗